Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Next generation FKBP52 targeting drugs for the treatment of prostate and breast cancer

Next generation FKBP52 targeting drugs for the treatment of prostate and breast cancer

US Patent 12351560 · Granted Jul 8, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Myc-Max inhibitor compound therapeutics for cancer treatment, methods and uses a2024
Next generation FKBP52 targeting drugs for the treatment of prostate and breast 2024
Next generation FKBP52 targeting drugs for the treatment of prostate and breast 2024
Next generation FKBP52 targeting drugs for the treatment of prostate and breast 2024
Pharmaceutical compositions directly targeting FKBP52 for the treatment of prost2020
Pharmaceutical compositions directly targeting FKBP52 for the treatment of prost2020
FKBP52 specific androgen receptor inhibitor, MJC13, for use in treating breast c2019
Pharmaceutical compositions directly targeting FKBP52 for the treatment of prost2019
Pharmaceutical compositions directly targeting FKBP52 for the treatment of prost2019
Intravenous formulation and LC/MS/MS analysis method for GMC12018
Human androgen receptor DNA-binding domain (DBD) compounds as therapeutics and m2018
Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen2017